The previous posts re COVID-19 “vaccine” adverse events have only reported figures from the US. This post includes figures from Europe, particularly the European Economic Area (EEA). Please note the different dates.
According to the Vaccine Adverse Event Reporting System (VAERS): as of 23 April 2021, there have been 118,902 adverse events reported for all COVID-19 “vaccines” in the US. This includes 3,544 deaths (3.0% of reported adverse events).
As of 23 April 2021, 222.32 million doses have been administered in the US. This figure is for doses, not the number of vaccinees since some people require two doses. Below is some back-of-the-envelope math.
118,902 adverse events for 222,320,000 doses: ~53.5 adverse events per 100,000 doses. Or, to put it differently: 1 adverse event per 1,870 doses.
According to the European Database of Suspected Adverse Drug Reaction Reports, the below are the number of reported adverse events with their corresponding “vaccine” as of 1 May 2021 in the EEA:
Astrazeneca – 83,666.
Moderna – 11,745.
Pfizer-Biontech (Tozinameran) – 127,852.
The reports can be called up at www.adrreports.eu/en/background.html. Other vaccines have been used but at significantly lower numbers.
As of 1 May 2021, the below are the doses administered in the EEA:
Astrazeneca – 34,011,576.
Moderna – 14,697,241.
Pfizer-Biontech (Tozinameran) – 107,091,613.
Below are some back-of-the-envelope calculations.
Astrazeneca – 83,666 adverse events for 34,011,576 doses: ~246.0 adverse events per 100,000 doses, or 1 adverse event per 407 doses.
Moderna – 11,745 adverse events for 14,697,241 doses: ~79.9 adverse events per 100,000 doses, or 1 adverse event per 1,251 doses.
Pfizer-Biontech (Tozinameran) – 127,852 adverse events for 107,091,613 doses: ~119.4 adverse events per 100,000 doses, or 1 adverse event per 838 doses.
Compare the above to the supposedly safe MMR vaccine: ~5 adverse events per 100,000 doses or ~1 adverse event per 20,000 doses.
What is perhaps more disturbing than these numbers are the figures for “Nervous system disorders” and “Blood and lymphatic system disorders”. See Figure 3 below.
I cannot explain the significant differences between the “vaccines” and the difference between the US and European figures. I suspect it is due to the personal choice of each recipient and medical professional on whether to report the issues, and perhaps the partially subjective nature of what is considered an adverse event (i.e. some people are simply more tolerant to less serious effects.)
Be sure to subscribe to our mailing list so you get each new Opinyun that comes out!